Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia (Q32100719)

6 July 2017

title

Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia (English)

1 reference

6 July 2017

1 reference

1 reference

1 reference

F Alvarez Lerma

1

1 reference

6 July 2017

Serious Infection Study Group

series ordinal

2

1 reference

6 July 2017

publication date

1 February 2001

1 reference

6 July 2017

published in

Journal of Chemotherapy

1 reference

6 July 2017

volume

13

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

70-81

1 reference

National Nosocomial Infections Surveillance (NNIS) Report, data summary for October 1986–April 1997, issued May 1997

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Etiology and Diagnosis of Pneumonia Requiring ICU Admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

The MYSTIC (meropenem yearly susceptibility test information collection) programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

A multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.1.70

release_d4t3li3ifrbk7ixypk2745i5f4

21 January 2018

Identifiers

DOI

10.1179/JOC.2001.13.1.70

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4t3li3ifrbk7ixypk2745i5f4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference